Caribou Biosciences (CRBU.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec8

US Bank Securities Analyst Maintains Buy Rating for Caribou Biosciences

00:02

Nov13

Asthika Goonewardene Reiterates Buy Rating on Caribou Biosciences

13:12

RBC Capital Analyst Maintains Buy Rating for Caribou Biosciences

12:22

Caribou Biosciences released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 2.198 M (forecast USD 1.857 M), actual EPS USD -0.2952 (forecast USD -0.3569)

04:00

Caribou Biosciences released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 7.218 M and EPS of USD -1.313

04:00

Aug13

Caribou Biosciences released FY2025 Semi-Annual earnings on August 12 (EST), actual revenue USD 5.02 M, actual EPS USD -1.0132

03:00

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 2.198 M, Net Income -27.55 M, EPS -0.2952

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.667 M, Net Income -54.1 M, EPS -0.5815

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 2.353 M, Net Income -39.99 M, EPS -0.4314

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change